FINELLI, CARLO

FINELLI, CARLO  

Mostra records
Risultati 1 - 20 di 55 (tempo di esecuzione: 0.048 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Man...zoli L.; Finelli C.; Cocco L. 2012-01-01 LEUKEMIA - 1.01 Articolo in rivista -
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C;
Mongiorgi S; Parisi S; Bosi C; ...
Manzoli L; Martinelli G; Cocco L;
Baccarani M
2011-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S;
Papayannidis C; Mongiorgi S; Parisi ...
S; Abbenante MC; Bosi C;
Manzoli L; Martinelli G; Cocco L; Cavo M
2013-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia...; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani 2012-01-01 BLOOD - 4.02 Riassunto (Abstract) -
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C;
Mongiorgi S; Parisi S; Abbenan...
te MC; Bosi C; Manzoli L;
Martinelli G; Cocco L; Baccarani M
2012-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A.... Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo 2011-01-01 LEUKEMIA RESEARCH - 4.02 Riassunto (Abstract) -
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani...; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo 2010-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes Finelli, Carlo; Follo, Matilde Y; Stanzani, Marta; Parisi, Sarah; Clissa, Cristina; Mongiorgi, Sa...ra; Barraco, Marilena; Cocco, Lucio 2016-01-01 CURRENT PHARMACEUTICAL DESIGN - 1.01 Articolo in rivista -
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta
M; Stanzani M; Martinelli G; Ma...
nzoli L; Cocco L; Finelli C
2013-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Man...zoli; C. Cocco; C. Finelli 2013-01-01 LEUKEMIA RESEARCH - 4.01 Contributo in Atti di convegno -
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani;... Michele Baccarani; Lucio Cocco 2013-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. Gattermann N; Finelli C; Porta MD; Fenaux P; Ganser A; Guerci-Bresler A; Schmid M; Taylor K; Vass...ilieff D; Habr D; Domokos G; Roubert B; Rose C; Baccarani M; EPIC study investigators. 2010-01-01 LEUKEMIA RESEARCH - 1.01 Articolo in rivista -
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES Follo, My; Mongiorgi, S; Clissa, C; Stanzani, M; Poli, A; Lonetti, A; Cappellini, A; Manzoli, L; ...Cocco L, 1; Finelli, C 2014-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carla Filì; Costanza Bosi; Maril...isa Quaranta; Stefania Paolini; Anna Maria Billi; Marco Gobbi; Michele Baccarani; Domenico Russo; Giovanni Martinelli; Lucia Manzoli; Lucio Cocco 2012-01-01 BLOOD - 4.02 Riassunto (Abstract) -
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients M.Y. Follo; S. Mongiorgi; C. Clissa; C. Filì; C. Colombi; M. Baccarani; G. Martinelli; M. Gobbi; ...L. Manzoli; D. Russo; C. Finelli; L. Cocco 2011-01-01 LEUKEMIA RESEARCH - 4.01 Contributo in Atti di convegno -
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele B...accarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco 2009-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
EFFECT OF LENALIDOMIDE ON INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS Follo MY;Mongiorgi S; Clissa C; Baccarani M; Paolini S;
Martinelli G; Manzoli L; Finelli C; Cocco L
2011-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni... Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco 2011-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; ...Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco 2010-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients Matilde Y. Follo; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Michele Baccarani; Giovanni Mar...tinelli; Patrizia Santi; Giulia Ramazzotti; Anna Maria Billi; Lucia Manzoli; Carlo Finelli; Lucio Cocco 2011-01-01 ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY - 4.01 Contributo in Atti di convegno -